Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors-Reference-Cited by-同舟云学术

Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors

Published:2021-06-23 Issue:11 Volume:81 Page:1243-1255
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Evans Marc,Morgan Angharad R.,Yousef Zaheer,Ellis Gethin,Dashora Umesh,Patel Dipesh C.,Brown Pam,Hanif Wasim,Townend Johnathan N.,Kanumilli Naresh,Moore Jim,Wilding John P. H.,Bain Stephen C.

Funder

AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-021-01538-6.pdf

Reference74 articles.

1. Vallon V, Thomson SC. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia. 2017;60(2):215–25. https://doi.org/10.1007/s00125-016-4157-3.

2. Saisho Y. SGLT2 inhibitors: the star in the treatment of type 2 diabetes? Diseases. 2020. https://doi.org/10.3390/diseases8020014.

3. Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, Bekiari E, et al. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013;159(4):262–74. https://doi.org/10.7326/0003-4819-159-4-201308200-00007.

4. Ghosh RK, Ghosh GC, Gupta M, Bandyopadhyay D, Akhtar T, Deedwania P, et al. Sodium glucose co-transporter 2 inhibitors and heart failure. Am J Cardiol. 2019;124(11):1790–6. https://doi.org/10.1016/j.amjcard.2019.08.038.

5. Staels B. Cardiovascular protection by sodium glucose cotransporter 2 inhibitors: potential mechanisms. Am J Cardiol. 2017;120(1s):S28-s36. https://doi.org/10.1016/j.amjcard.2017.05.013.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Patients on SGLT2 Inhibitors in Primary Care;JACC: Heart Failure;2024-06

2. The role of SGLT-2 inhibitors on health-related quality of life, exercise capacity, and volume depletion in patients with chronic heart failure: a meta-analysis of randomized controlled trials;International Journal of Clinical Pharmacy;2023-02-17

3. Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently;Diabetes Therapy;2022-03-29